vs
布鲁姆能源（CLNE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是布鲁姆能源的2.0倍（$219.9M vs $112.3M），Orthofix Medical Inc.净利率更高（-1.0% vs -38.3%，领先37.3%），布鲁姆能源同比增速更快（2.7% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $6.5M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.1%）
布鲁姆能源是一家美国上市企业，设计并制造固体氧化物燃料电池，该产品可在数据中心、制造业及其他商业领域的场所内独立发电。公司成立于2001年，总部位于加利福尼亚州圣何塞，其技术依靠化学转化过程发电，无需依赖传统燃烧，可使用天然气、沼气或氢气作为燃料。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CLNE vs OFIX — 直观对比
营收规模更大
OFIX
是对方的2.0倍
$112.3M
营收增速更快
CLNE
高出0.8%
2.0%
净利率更高
OFIX
高出37.3%
-38.3%
自由现金流更多
OFIX
多$10.3M
$6.5M
两年增速更快
OFIX
近两年复合增速
4.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.3M | $219.9M |
| 净利润 | $-43.0M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -9.5% | 0.2% |
| 净利率 | -38.3% | -1.0% |
| 营收同比 | 2.7% | 2.0% |
| 净利润同比 | -42.6% | 92.4% |
| 每股收益（稀释后） | $-0.21 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLNEOFIX
| Q4 25 | $112.3M | $219.9M | ||
| Q3 25 | $106.1M | $205.6M | ||
| Q2 25 | $102.6M | $203.1M | ||
| Q1 25 | $103.8M | $193.6M | ||
| Q4 24 | $109.3M | $215.7M | ||
| Q3 24 | $104.9M | $196.6M | ||
| Q2 24 | $98.0M | $198.6M | ||
| Q1 24 | $103.7M | $188.6M |
净利润CLNEOFIX
| Q4 25 | $-43.0M | $-2.2M | ||
| Q3 25 | $-23.8M | $-22.8M | ||
| Q2 25 | $-20.2M | $-14.1M | ||
| Q1 25 | $-135.0M | $-53.1M | ||
| Q4 24 | $-30.2M | $-29.1M | ||
| Q3 24 | $-18.2M | $-27.4M | ||
| Q2 24 | $-16.3M | $-33.4M | ||
| Q1 24 | $-18.4M | $-36.0M |
毛利率CLNEOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率CLNEOFIX
| Q4 25 | -9.5% | 0.2% | ||
| Q3 25 | -12.8% | -8.3% | ||
| Q2 25 | -9.0% | -7.9% | ||
| Q1 25 | -121.7% | -25.2% | ||
| Q4 24 | -11.8% | -5.3% | ||
| Q3 24 | -8.1% | -9.6% | ||
| Q2 24 | -5.7% | -12.5% | ||
| Q1 24 | -9.0% | -15.6% |
净利率CLNEOFIX
| Q4 25 | -38.3% | -1.0% | ||
| Q3 25 | -22.4% | -11.1% | ||
| Q2 25 | -19.7% | -6.9% | ||
| Q1 25 | -130.1% | -27.4% | ||
| Q4 24 | -27.6% | -13.5% | ||
| Q3 24 | -17.3% | -13.9% | ||
| Q2 24 | -16.6% | -16.8% | ||
| Q1 24 | -17.8% | -19.1% |
每股收益（稀释后）CLNEOFIX
| Q4 25 | $-0.21 | $-0.05 | ||
| Q3 25 | $-0.11 | $-0.57 | ||
| Q2 25 | $-0.09 | $-0.36 | ||
| Q1 25 | $-0.60 | $-1.35 | ||
| Q4 24 | $-0.14 | $-0.76 | ||
| Q3 24 | $-0.08 | $-0.71 | ||
| Q2 24 | $-0.07 | $-0.88 | ||
| Q1 24 | $-0.08 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.1M | $82.0M |
| 总债务越低越好 | $226.8M | — |
| 股东权益账面价值 | $559.4M | $450.0M |
| 总资产 | $1.1B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.41× | — |
8季度趋势，按日历期对齐
现金及短期投资CLNEOFIX
| Q4 25 | $156.1M | $82.0M | ||
| Q3 25 | $232.2M | $62.9M | ||
| Q2 25 | $240.8M | $65.6M | ||
| Q1 25 | $226.6M | $58.0M | ||
| Q4 24 | $217.5M | $83.2M | ||
| Q3 24 | $243.5M | $30.1M | ||
| Q2 24 | $249.3M | $26.4M | ||
| Q1 24 | $248.9M | $27.0M |
总债务CLNEOFIX
| Q4 25 | $226.8M | — | ||
| Q3 25 | $284.3M | $157.2M | ||
| Q2 25 | $277.9M | $157.0M | ||
| Q1 25 | $271.6M | $156.9M | ||
| Q4 24 | $265.4M | $157.0M | ||
| Q3 24 | $264.1M | $118.5M | ||
| Q2 24 | $263.0M | $118.0M | ||
| Q1 24 | $262.0M | $118.2M |
股东权益CLNEOFIX
| Q4 25 | $559.4M | $450.0M | ||
| Q3 25 | $585.2M | $442.5M | ||
| Q2 25 | $590.8M | $458.3M | ||
| Q1 25 | $596.7M | $458.3M | ||
| Q4 24 | $713.3M | $503.1M | ||
| Q3 24 | $724.8M | $525.9M | ||
| Q2 24 | $723.0M | $546.0M | ||
| Q1 24 | $722.9M | $570.3M |
总资产CLNEOFIX
| Q4 25 | $1.1B | $850.6M | ||
| Q3 25 | $1.1B | $832.6M | ||
| Q2 25 | $1.1B | $837.2M | ||
| Q1 25 | $1.1B | $823.1M | ||
| Q4 24 | $1.2B | $893.3M | ||
| Q3 24 | $1.2B | $867.9M | ||
| Q2 24 | $1.2B | $882.0M | ||
| Q1 24 | $1.2B | $906.0M |
负债/权益比CLNEOFIX
| Q4 25 | 0.41× | — | ||
| Q3 25 | 0.49× | 0.36× | ||
| Q2 25 | 0.47× | 0.34× | ||
| Q1 25 | 0.46× | 0.34× | ||
| Q4 24 | 0.37× | 0.31× | ||
| Q3 24 | 0.36× | 0.23× | ||
| Q2 24 | 0.36× | 0.22× | ||
| Q1 24 | 0.36× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $16.8M |
| 自由现金流率自由现金流/营收 | 5.8% | 7.6% |
| 资本支出强度资本支出/营收 | 5.9% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $59.9M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流CLNEOFIX
| Q4 25 | $13.1M | $27.7M | ||
| Q3 25 | $13.1M | $12.4M | ||
| Q2 25 | $35.9M | $11.6M | ||
| Q1 25 | $23.4M | $-18.4M | ||
| Q4 24 | $21.9M | $23.7M | ||
| Q3 24 | $21.4M | $11.7M | ||
| Q2 24 | $18.8M | $9.0M | ||
| Q1 24 | $2.6M | $-18.6M |
自由现金流CLNEOFIX
| Q4 25 | $6.5M | $16.8M | ||
| Q3 25 | $6.5M | $2.5M | ||
| Q2 25 | $30.9M | $4.5M | ||
| Q1 25 | $15.9M | $-25.1M | ||
| Q4 24 | $10.3M | $15.2M | ||
| Q3 24 | $42.0K | $6.3M | ||
| Q2 24 | $4.8M | $-360.0K | ||
| Q1 24 | $-15.6M | $-29.1M |
自由现金流率CLNEOFIX
| Q4 25 | 5.8% | 7.6% | ||
| Q3 25 | 6.1% | 1.2% | ||
| Q2 25 | 30.2% | 2.2% | ||
| Q1 25 | 15.4% | -13.0% | ||
| Q4 24 | 9.5% | 7.0% | ||
| Q3 24 | 0.0% | 3.2% | ||
| Q2 24 | 4.9% | -0.2% | ||
| Q1 24 | -15.1% | -15.4% |
资本支出强度CLNEOFIX
| Q4 25 | 5.9% | 4.9% | ||
| Q3 25 | 6.2% | 4.8% | ||
| Q2 25 | 4.8% | 3.5% | ||
| Q1 25 | 7.2% | 3.5% | ||
| Q4 24 | 10.5% | 4.0% | ||
| Q3 24 | 20.3% | 2.7% | ||
| Q2 24 | 14.2% | 4.7% | ||
| Q1 24 | 17.6% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLNE
| Volume Related Fuel Sales | $73.6M | 66% |
| Services | $15.1M | 13% |
| Station Construction Sales | $10.7M | 9% |
| Volume Related Renewable Identification Number Credits | $9.5M | 8% |
| Volume Related Low Carbon Fuel Standard Credits | $3.4M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
